Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — |
| R&D | $0 | $0 | $112.77B | $202.9M |
| Operating income | −$90.8K | −$4.6M | $0 | $0 |
| EBITDA | −$90.8K | −$4.5M | $1.4M | $2.6M |
| Net income | −$90.8K | −$4.5M | −$120.68B | −$229.1M |
| Net margin | — | — | — | — |
| EPS (diluted) | -0.01 | -0.30 | -1.89 | -3.53 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds HLXA.
No tracked institution reports a position in HLXA as of their last filing.
No one on the platform has traded HLXA yet.
| +11.66% |
| $566M |
| — |
| SAGASagaliam Acquisition Corp. | $10.88 | -0.09% | $587M | — |
| TCVATCV Acquisition Corp. | $10.23 | -0.05% | $523M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.